QIAGEN N.V.’s QGEN fourth-quarter 2024 adjusted earnings per share (EPS) were 61 cents, the same at the constant exchange ...

In a report released on February 6, Casey Woodring from J.P. Morgan maintained a Buy rating on Qiagen (QGEN – Research Report), with a price ...

Q4 2024 Management View Thierry Bernard, CEO, highlighted that Qiagen surpassed its Q4 2024 sales and adjusted earnings targets, with net sales reaching $521 million at 3% CER growth, exceeding the ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court ...

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Buy rating on Qiagen (QGEN – Research Report). The company’s ...

Qiagen (QGEN) reported $521.2 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 2.4%. EPS of $0.61 for the same period compares to $0.57 a year ago. The ...

Net sales of $521 million (+2% actual rates, +4% constant exchange rates (CER) core growth); diluted EPS of $0.39 and ...

Qiagen QGEN reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:05 PM. Here's what investors need to know ...

Qiagen (NYSE:QGEN – Get Free Report) is expected to post its quarterly earnings results after the market closes on Wednesday, ...

The diagnostic products maker posted revenue of $521.2 million in the period, beating Street forecasts. Seven analysts surveyed by Zacks expected $520.7 million. Qiagen expects full-year earnings to ...

Qiagen missed estimated earnings by -2.0%, reporting an EPS of $0.61 versus an estimate of $0.62. Revenue was up $11.84 million from the same period last year. The company beat on EPS by $0.03 in the ...